Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera
Glaucoma Eye, Macular Degeneration, Macula Abnormality
About this trial
This is an interventional diagnostic trial for Glaucoma Eye focused on measuring hyperspectral, retinoscopy, oxygenation, non-invasive
Eligibility Criteria
For inclusion in the investigation, the patient-subjects must fulfill all of the below criteria prior to enrollment: 1. Age > 18 years. 2. Ophthalmological disease, disorder, illness or problem involving the retina 3. Provision of informed consent i.e., subject must be able to understand and sign the patient information and consent form. For inclusion in the investigation, the healthy subjects must fulfill all of the below criteria prior to enrollment:
- Age >18 years.
- Without known eye disease.
- Provision of informed consent i.e., subject must be able to understand and sign the patient information and consent form.
Patients-subjects who meet any of the below criteria will be excluded from the investigation:
- Patients with narrow angle glaucoma
- Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the Principal Investigator. Healthy subjects who meet any of the below criteria will be excluded from the investigation:
1. Presence of eye disease, eye trauma, diabetes or pregnancy. 3. Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the Principal Investigator.
Sites / Locations
- Sundets Ögonläkare
Arms of the Study
Arm 1
Experimental
Camera test group
The Principal Investigator will take a hyperspectral image of all subjects, both healthy volunteers and patients.